Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Nutt

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Genetic Testing|October 6, 2006
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's diseaseDenise M Kay, Tom D Bird, Cyrus P Zabetian, et al.
Archives of Neurology|October 11, 2002
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional declineClifford W Shults, David Oakes, Karl Kieburtz, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Mass Spectrometry Reviews|April 10, 2009
Glycoproteomics in neurodegenerative diseasesHyejin Hwang, Jianpeng Zhang, Kathryn A Chung, et al.
Nature Genetics|August 17, 2010
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseTaye H Hamza, Cyrus P Zabetian, Albert Tenesa, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disordersFadi Abdi, Joseph F Quinn, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2008
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing deviceChristopher G Goetz, Glenn T Stebbins, David Wolff, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
Journal of Parkinson'S Disease|May 24, 2020
Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's DiseaseDanique L M Radder, Jorik Nonnekes, Marlies van Nimwegen, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Genetic Testing|October 6, 2006
Validity and utility of a LRRK2 G2019S mutation test for the diagnosis of Parkinson's diseaseDenise M Kay, Tom D Bird, Cyrus P Zabetian, et al.
Archives of Neurology|October 11, 2002
Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional declineClifford W Shults, David Oakes, Karl Kieburtz, et al.
American Journal of Human Genetics|February 24, 2005
Identification of a novel LRRK2 mutation linked to autosomal dominant parkinsonism: evidence of a common founder across European populationsJennifer Kachergus, Ignacio F Mata, Mary Hulihan, et al.
Mass Spectrometry Reviews|April 10, 2009
Glycoproteomics in neurodegenerative diseasesHyejin Hwang, Jianpeng Zhang, Kathryn A Chung, et al.
Nature Genetics|August 17, 2010
Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's diseaseTaye H Hamza, Cyrus P Zabetian, Albert Tenesa, et al.
Journal of Alzheimer'S Disease : JAD|August 18, 2006
Detection of biomarkers with a multiplex quantitative proteomic platform in cerebrospinal fluid of patients with neurodegenerative disordersFadi Abdi, Joseph F Quinn, Joseph Jankovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|December 17, 2008
Testing objective measures of motor impairment in early Parkinson's disease: Feasibility study of an at-home testing deviceChristopher G Goetz, Glenn T Stebbins, David Wolff, et al.
The Lancet. Neurology|October 26, 2010
Gene delivery of AAV2-neurturin for Parkinson's disease: a double-blind, randomised, controlled trialWilliam J Marks, Raymond T Bartus, Joao Siffert, et al.
Journal of Parkinson'S Disease|May 24, 2020
Recommendations for the Organization of Multidisciplinary Clinical Care Teams in Parkinson's DiseaseDanique L M Radder, Jorik Nonnekes, Marlies van Nimwegen, et al.
Plos Genetics|August 31, 2011
Genome-wide gene-environment study identifies glutamate receptor gene GRIN2A as a Parkinson's disease modifier gene via interaction with coffeeTaye H Hamza, Honglei Chen, Erin M Hill-Burns, et al.
Pageof 6